Diseases, Conditions, Syndromes

Risk for vitiligo increased for transplant recipients

Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published online Dec. 13 in JAMA Dermatology.


AAD: Long-term improvement seen with ruxolitinib in vitiligo

For patients with nonsegmental vitiligo, continued improvement in seen during a long-term extension of ruxolitinib treatment, according to study presented at the annual meeting of the American Academy of Dermatology, held ...

page 1 from 4